Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study.

[1]  P. Mannucci,et al.  A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. , 2004, Blood.

[2]  I. Wiegratz,et al.  Effect of four oral contraceptives on hemostatic parameters. , 2004, Contraception.

[3]  Task Force on Long-acting Systemic Agents for Fertility Regulaion.  Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis. , 2003, Contraception.

[4]  A. Folsom,et al.  Fibrin fragment D-dimer and the risk of future venous thrombosis. , 2003, Blood.

[5]  S. Kreiner,et al.  Contraceptives and cerebral thrombosis: a five-year national case-control study. , 2002, Contraception.

[6]  S. Kreiner,et al.  Oral contraceptives and venous thromboembolism: a five-year national case-control study. , 2002, Contraception.

[7]  N Rifai,et al.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.

[8]  J. Danesh,et al.  Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis , 2001, Circulation.

[9]  V. Salomaa,et al.  Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[10]  K. Kugiyama,et al.  Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women. , 2001, The American journal of cardiology.

[11]  H. Cohen,et al.  Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.

[12]  A. Sharrett,et al.  Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[13]  L. Kuller,et al.  Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[14]  P. Ridker,et al.  Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. , 1994, Circulation.

[15]  G. Allam,et al.  Effect of depo-medroxyprogesterone acetate on coagulation factors and serum lipids in Egyptian women. , 1991, Contraception.

[16]  S. Noguchi,et al.  Changes in Hematologic Parameters during Treatment with Medroxyprogesterone Acetate for Breast Cancer , 1991, Japanese journal of cancer research : Gann.

[17]  P. Mombaerts,et al.  Fibrinolytic Response and Fibrin Fragment D-Dimer Levels in Patients with Deep Vein Thrombosis , 1987, Thrombosis and Haemostasis.

[18]  A. Kjaeldgaard,et al.  Progestogen regulation of tissue plasminogen activator in a human melanoma cell line. , 1986, Thrombosis research.

[19]  W. Inman,et al.  Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs , 1970, British medical journal.

[20]  F. Rosendaal,et al.  D-Dimer as a Risk Factor for Deep Vein Thrombosis: The Leiden Thrombophilia Study , 2002, Thrombosis and Haemostasis.